Jon Congleton

Jon Congleton is a seasoned professional with an extensive background in the pharmaceutical industry, spanning various roles over the course of his career.

With a solid educational foundation in marketing from Kansas State University, Jon has built a successful career that includes significant leadership positions in renowned pharmaceutical companies.

His expertise covers executive leadership, strategy development, commercial operations, and HR/culture management.

Jon has held key positions such as Chief Executive Officer at Mineralys Therapeutics, Inc., President and CEO at Impel NeuroPharma, and President and CEO at Nivalis Therapeutics Inc.

Prior to these roles, he served as the Senior Vice President Global Medicines Group at Teva Pharmaceuticals, where he also held the positions of SVP Global Strategic Marketing, VP GM US Division, VP GM Canadian Division, and Director of COPAXONE Marketing.

Before his tenure at Teva Pharmaceuticals, Jon's career journey included roles such as District Sales Manager and Human Resource Manager at Marion Merrell Dow, Inc., as well as Sales Representative at Marion Laboratories.

Throughout his career, Jon has accumulated valuable experience with 4 years in field-based sales positions, 2 years in HR management, 5 years in field sales management, 6 years in pharmaceutical marketing as both a PM and a director, 4 years as GM of Canada, 2 years as GM in the US, 3 years in a global role with a multinational corporation, and 5 years as a CEO in private and public companies.

Jon's professional strengths lie in his ability to lead organizations, develop strategic initiatives, drive commercial success, and foster positive HR practices and workplace culture.

With his background and expertise, Jon Congleton continues to be a respected figure in the pharmaceutical industry, known for his impactful contributions and accomplishments.